This article was originally published in The Gray Sheet
Polysomnographic data should be collected to support an intended use for obstructive sleep apnea, FDA recommends in an 1April 5 special controls draft guidance for intraoral devices for snoring and/or sleep apnea. The draft guidance accompanies a 2proposed rule that seeks to categorize the unclassified preamendments devices as Class II with special controls. Comments on the guidance and proposed rule are due by July 5...
You may also be interested in...
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.
Skin hygiene is one of several categories where Edgewell Personal Care has a “right to win" after 18 months of renovations, according to the company’s 20 November Investor Day presentation. The firm has doubled its production capacity and has plans for a “full suite” of product innovation to build on Wet Ones’ 60% growth in fiscal 2020.
Considerable value has been assigned to the companies developing coronavirus vaccines. Multiple suppliers and a met clinical need may erode much of that value after the pandemic.